Peter Heerma

EVP, Chief Commercial Officer, Travere Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$18.9M

Companies

Latest trade

Sep 17, 2026

Companies

Travere Therapeutics, Inc.EVP, Chief Commercial Officer −$19.0M

Trades

TVTX Sold 8,282 shares at $65.07 · planned $0.5M Sep 17

TVTX Sold 172,717 shares at $63.43 · planned $11.0M Sep 16

TVTX Sold 102,190 shares at $62.26 · planned $6.4M Sep 15

TVTX Sold 2,174 shares at $46.65 $0.1M May 5

TVTX Sold 7,215 shares at $41.93 $0.3M Apr 14

TVTX Sold 7,310 shares at $32.12 $0.2M Feb 3

TVTX Sold 4,980 shares at $40.00 · planned $0.2M Dec 24

TVTX Sold 5,591 shares at $35.00 · planned $0.2M Oct 31

TVTX Sold 2,662 shares at $30.00 · planned $0.1M Oct 28

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.